Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

0.7699
+0.02563.44%
Volume:596.89K
Turnover:450.96K
Market Cap:61.67M
PE:2.04
High:0.7743
Open:0.7400
Low:0.7242
Close:0.7443
Loading ...

Allogene's Q4 Loss Narrower Than Expected, Revenues Nil

Zacks
·
14 Mar

CytomX Therapeutics (CTMX) Upgraded to Strong Buy: Here's What You Should Know

Zacks
·
12 Mar

CytomX Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
08 Mar

CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability

TIPRANKS
·
08 Mar

CytomX Therapeutics’ Earnings Call Highlights Progress and Challenges

TIPRANKS
·
08 Mar

CytomX Therapeutics, Inc. (CTMX): Among the Cheap Growth Stocks to Buy Now

Insider Monkey
·
08 Mar

Q4 2024 CytomX Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
07 Mar

Cautious Outlook for CytomX Therapeutics Amid Pipeline Challenges and Strategic Setbacks

TIPRANKS
·
07 Mar

Barclays Remains a Buy on CytomX Therapeutics (CTMX)

TIPRANKS
·
07 Mar

CytomX Therapeutics Inc (CTMX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
07 Mar

CytomX Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

CytomX Therapeutics (CTMX) Tops Q4 Earnings and Revenue Estimates

Zacks
·
07 Mar

CytomX Therapeutics Q4 GAAP EPS $0.23 Beats $(0.20) Estimate, Sales $38.09M Beat $19.42M Estimate

Benzinga
·
07 Mar

CytomX Therapeutics Inc -Maintained Financial Strength With Cash Runway Into Q2 2026

THOMSON REUTERS
·
07 Mar

CytomX Therapeutics FY Operating Income USD 24.995 Million

THOMSON REUTERS
·
07 Mar

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

GlobeNewswire
·
07 Mar

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

GlobeNewswire
·
05 Mar

CytomX Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
05 Mar

CytomX Gears Up to Report Q4 Earnings: What Should Investors Expect?

Zacks
·
04 Mar

CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

GlobeNewswire
·
27 Feb